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Leptomycin B is an inhibitor of nuclear export: inhibition of 
nucleo-cytoplasmic translocation of the human immunodeficiency 
virus type 1 (HIV-l) Rev protein and Rev-dependent mRNA 
Barbara Wolff’, Jean-Jacques Sangher and Ying Wang2 
Background: The human immunodeficiency virus type 1 (HIV-I) regulatory protein 
Rev is required for unspliced and incompletely spliced viral mRNAs to appear in 
the cytoplasm and thus for viral replication. Translocation of Rev from the nucleus 
to the cytoplasm is essential if Rev is to function. We wanted to identify inhibitors 
of this transport process because they would be potential antiviral agents. 
Results: The Streptomyces metabolite, leptomycin 8, and other antibiotics of 
the leptomycinlkazusamycin family were identified as inhibitors of the 
nucleo-cytoplasmic translocation of Rev at nanomolar concentrations. Rev- 
dependent export of mRNA into the cytoplasm is also blocked by leptomycin B, 
which inhibits Rev-dependent, but not Rev-independent gene expression in a 
short-term transfection assay. In primary human monocytes, leptomycin B 
suppresses HIV-l replication. 
Conclusions: Leptomycin B is the first low molecular weight inhibitor of nuclear 
export to be identified. Although it cannot be used therapeutically, it should serve 
as a valuable tool for dissecting nuclear evporl pathways 
Introduction 
The acquired immunodeficiency syndrome (AIDS) is a 
life-threatening disease caused by HIV-l [l]. The HIV-1 
genome encodes several regulatory proteins, in particular 
Tat and Rev, that are essential for virus replication [2;3j. 
Rev is necessary for the appearance in the cytoplasm of 
unspliced and singly spliced viral mRNAs that encode 
the structural proteins Gag, Pal and Env [4,5]. Rev is a 
nuclear protein [6] and it interacts with a highly structured 
RNA, the Rev response element (RRE), in the viral LED 
gene [7-101. 
Since Rev is a viral protein lacking a cellular counterparr, 
scvc~al different strategies have been employed to inhibit 
HIV-1 replication by inhibiting the function of the Rev 
protein. One strategy has heen to use anrisense phospho- 
rothioace oligonucleotides against Rev to suppress HlV 
in chronically infected cells [ll]. Using gene therapy 
approaches, tmnc-dominant mutants of HIV-1 Rev [12], 
dominant-negative mufants of the ccllnlar Rev cofactor 
eIF-5.4 [13], intracellular expression of an anti-Rev single 
chain antibody construct [14], and RR&decoys [15] have 
all been shown to inhibit lIIV-1 infection in cells. In a more 
classical approach using low molecular weight substances, 
neomycin was found IO block Rev-RRE binding and to 
antagonize Rev function [16] and an %alkylpyrimidinone 
was found to antagonize cellular Rev response [17]. 
Recently, we and others have demonstrated that the export 
of Rev from the nucleus to the cytoplasm is crucially 
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important for its function and the export depends on the 
Rev activation domain [l&-20], which serves as a nuclear 
export signal [21,22]. Rev translocates from the nucleus to 
the cytoplasm in HeLa and COS cells transfected with Rev 
under conditions where rRNA synthesis is inhibited by, 
for example, actinomycin D (AD). It is clear that the 
appearance of Rev in the cytoplasm reflects export and nor 
de now synthesis of Rev protein in the cytoplasm, because 
the reaction takes place in the presence of the protein 
synthesis inhibitor, cycloheximide 11%201. Furthermore, 
dominant-negative mutants of Rev with mutations in the 
activation domain (nuclear export signal) are unable to 
leave the ndcleus upon treatment with AD [lS-201. 
In a screening assay for low molecular weight inhibitors of 
Rev nuclear export, we have now found four antibiotics of 
the leptomycinlkazusamycin family that completely block 
this process at nanomolar concentrations. 1,eptomycin B 
(LMB) also inhibits Rev fnnction and HIV-l replication. 
Results 
LME inhibits cytoplasmic localization of Rev, but not 
protein transport into the nucleus 
Nucleo-cytoplasmic translocarion of Rev induced by AD 
in HeLa cells transfected with Rev (HeLa-Rev cells) was 
used as a screen for inhibitors of Rev function. A strepto- 
mycete extract was identified with very potent inhibitory 
activity, and four compounds, leptomycins A and B and 
kazusamycins A and B (Fig. l), were isolated as the 
activ~~components. 
Leptomycin A j % CH, 
kptomycin S W CH,CH, 
Kazusamycin A CH,OH CH,CH, 
Karusamycin S CH,OH W 
Structures of leptomycin and kazusamycin antibiotics, 
When HeLa-Rev cells were serum-starved, they did nor 
produce appreciahlc amounts of Rev protein (Fig. Za). 
Rev synthesis starred within 1 h of xwm addition, and the 
protein was observed to he in the nucleoli when a thin 
optical section (0.7 km) was taken with the confocal micro- 
scope (Fig. Zb). But, a thicker optical section (1.8b.m) 
revealed that low lcvcls of Rev were also always present in 
the cytoplasm (Fig. Zc). After 7 h, a high level of Rev was 
reached (Fig. 3a) and if, during the last 2 h of the incuha- 
tion, AD was added, Rev was almost exclusively localized 
in the cytoplasm (Fig. 3h). 
Upon incubation with LMB, the appearance of Rev in 
the cytoplasm was completely inhibited and Rev was 
localized instead to the nucleoplasm and the outer rim of 
the nucleoli~ (Fig. 3d). This nuclear retention was most 
obvious in the AD-treated cultures, but was also clearly 
visible in the ahscncc of AD (Fig. Zd). In this experiment, 
the cells had heen preincubated with 2nM LMB for 1 h 
hcfore the addition of serum and then further incubated 
Figure 2 
Rev localization in H&a-Rev ceils. H&-Rev 
cells were serum-starved for 48 h and fixed 
either (8) immediately or (b, c) after 1 h of 
serum addition to stimulate Rev synthesis. (d) 
Cells were preincubated with 2 nM LMS for 
1 h before the addition oi serum, after which 
they were incubated for a further 1 h. Cells 
were immunastained ior Rev protein and 
examined by confocal microscopy as 
described in the Materials and methods 
section. Note that the thickness of the optical 
sections is 0.7 pm for (a,b) but 1.8 &rn ior 
(c,d). Scale bar is 10 pm. 
for lh. As revealed by the thick optical section of the 
confocal microscope (Fig. Zd), the low levels of Rev 
immunoreactiviry seen in the cytoplasm in the absence of 
LMB (Fig. Zc) had completely disapprxed. ‘The prcs- 
encc of cycloheximide did not change either the nuclear 
export induced by AD [tS-201 or its inhibition by LMB 
(data not shown). While the results depicted in Figures 2 
and 3 WSK obtained with a total incubation time with the 
drug of 2 h and 7 h, respectively, the effect of LMB on 
nuclear accumulation of Rev could be observed as early 
as 30 min after the addition of the drug (data nor shown). 
In order to find out whether this effect was a general 
inhibition of nucleo-cytoplasmic trafficking, the effect of 
LMB on Rev nuclear import was investigated. HcLa- 
Rev cells were incubated with LMB for 1 h before the 
addition of serum to induce Rev synthesis. This incuba- 
tion had no effect on the nucleolar localization of Rev, 
even after another 7h of incubation (Fig. 3~). Taken 
together, the results shown in Figures 2 and 3 indicate 
Figure 3 
Effect of LMB on the subcellular localization of 
Rev. HeLa.Re” cells were serum-starved for 
48 h and then stimulated to synthesize Rev by 
the addition of serum. After 7 h. ceik were 
fixed and immunostained for Rev protein as 
described in the Materials and methods 
section. (a) Control cells incubated with 
medium only; (b) cells incubated with 
1 kg ml-’ AD during the last 2 h; (c) ells pre- 
incubated with 2 &M LMB for 1 h in serum 
free medium and then with complete medium 
containing LMB for 7 h: and Cd) cells 
incubated with medium containing 2 CM LMB 
for 7 h and 1 p.g ml-’ AD during the last 2 h. 
The thickness of the optical sections IS 
0.7 wm. Scale bar is 10 p.m. 
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that LMB specifically blocks nuclear exporr, but nor 
import of HIV-1 Rev. 
In order m characterize further the effect of LMB on 
nuclear protein import and in order to exclude the possi- 
bility that import would be inhibited at higher drug con- 
centrations, an in vWo test system and an ix oirrv text 
system were used. 
The p65 subunit of the transcription factor NFKB has 
been shown to translocare from the cytoplasm into the 
nucleus upon cell activation with, for example, tumor 
~CCIOS~S factor a (TNF-a) [23,241. The protein NFKB 
uses a classical nuclear localization signal (NLS) that is 
masked by binding to IKB in the absence of stimulation 
[25,26]. When HeLa cells were grown in medium, NFKB 
1~65 was localized in the cytoplasm (Fig. 4a). After incuba- 
tion with TNF-a for 30 min, most of the protein had 
translocated to the nucleus (Fig. 4b). This nuclear import 
was not affected by the presence of 1 &M LMB 30 min 
Figure 4 
Nuclear import of NFKB p65 in the presence of LMB. HeLa cells were fixed and stained for NFKEI p65 as described in the Materials and methods 
section. (a) Control cells incubated with medium only; (b) cells stimulated with 200U ml-’ TNF-a for 30 min to induce nuclear localization of ~65; 
and W cells incubated with 1 +M LMB for 30 min before and during the stimulation with TNF-a. Scale bar is 20 km. 
before and during the TNF-a ~~eafmcnc (Fig. 4~). Simi- 
larly, in COS cells the nuclear localization of SV40 Large 
T antigen was not affected even after a 48 h inabation 
with LMB (data not shown). 
Nuclear import can be reconstituted in z&o in an assay 
using semi-permeabilized HeLa cells and a fluorescent 
import substrate, for example, FITC-labelled bovine 
serum albumin (BSA) coupled fo a synthetic peptide 
conmining the SV40 1,arg.e T antigen nuclear localization 
Fioure 5 
signal (I’ITC-BSA-NLS) [27]. After a 30 min exposure 
of this import substrate with digitonin-pcrmeahilized 
HeLa cells in the presence of I-l&a cell cyrosol, the 
fluorescent protein was taken up by the nuclei (Fig. Sa). 
This import was not affected by the presence of 1pM 
,LMB (Fig. Sb), but was almost completely abolished 
by the addition of the import inhibitor GTPyS [28] (Fig. 
5c) or by performing the reaction at 0°C (Fig. Sd), which 
prevents the active transport process involved in nuclear 
import [271. In vitro uclear import assay in 
semi-permeabilized HeLa ceils. 
Digitonin-permeabilized HeLa ceils were 
incubated with HeLa cytosal and FITC- 
BSA-NLS nuclear import substrate as 
described f271. (a) Import oi FITC-BSA-NLS; 
(b) in the presence of 1 $4 LMB; (c) in the 
presence of 0.5 ,dv, GTP-,S: and (d) at 0°C. 
Scale bar is 15 em. 
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Taken together, the in viva and in vitro import results 
show that LMB has no effect on protein import, even at 
concentrations more than lOOO-fold higher than chose 
required for the inhibition of Rev export (Table 1). 
An inhibitory effect on Rev export was found not just for 
LMB but also for- lepromycin A and kazusamycins A and 
B. The concentrations required for a 50% inhibition of 
transport are given in Table 1, togethcr with the values for 
the antiproliferative effect after 7h, 24h, 48h and 72h. 
While that: appeared to be a rherapcutic window after 
short periods of incubation (7h and 24h), the concentra- 
tions required for inhibition of Rev export and 50% inhibi- 
tion of cell growth aftcr 72h were almost identical. 
Thcreforc, for most subsequent experiments, incubation 
times shorter than 72 h had to be chosen in order to evalu- 
ate a Rev-sprcific effect. Since LMB was the most abun- 
dant and the most potent of the four S~~ptomyces 
metabolitcs, it was used for all additional experiments. 
LMB inhibits the appearance of RRE-containing mRNA in 
the cytoplasm 
In order to find out whether inhibition of Rev export from 
the nucleus would, as a consequence, prevent the appear- 
ance of RRE-containing mRNA in the cytoplasm, COS 
cells were co-rransfecced with expression plasmids for Rev 
and for Tat. The Tat plasmid contains an RRE, so its 
expression is dcpendcnt on Rev function [29]. ‘l-he cells 
were treated with LMR for 2411 or 48 h, and cyroplasmic 
and nuclear RNA were prepared. Slot blot analysis was 
performed using a probe specific for RRE and a probe for 
18s RNA to control the RNA loading of the blot (Fig. 6). 
In a parallel experiment, transfected COS cells were 
analyzed for the subcellular localization of Rev protein 
Table 1 
Inhibition of Rev translocation and proliferation by leptomycin 
and kazusamycin antibiotics. 
7h 24h 48h 72h 7h 24h 48h 72h 
Leptomycin A 0.6 0.6 2.6 8.6 >*o 13.8 5.5 2.6 
Leptamycin B 0.1 0.2 0.3 0.6 >20 12.6 1 0.9 
Kazusamycin A 0.8 0.8 1.4 2.5 >20 10 3.7 2.9 
Karusamycin B 8.3 8.3 6.8 20 >20 920 7.8 7.4 
HeLa-Rev cells were seeded into 96well plates and allowed to adhere 
overnight. They were then incubated with drugs for the time periods 
indicated. For the evaluation of Rev transport inhibition. AD was added to 
a final concentration of 1 mg ml-’ during the last 2 h of incubatirin. This 
addition had no effect on the cell number. Cells were fixed and 
immunastained for Rev, and, after microscopic examination, futiher incu. 
b&d with sulforhodamine 8 to determine cellular protein, as described in 
the Materials and methods section. Results were calculated ham triplicate 
experiments. *Concentrations at which Rev nucleo-cytoplasmic transpoti 
wan inhibited by 50%. ‘Concentration which caused a 50% reduction in 
cell number as compared to untreated controls (IC,,). 
Figure 6 
I RRE 16s RNA N C N C 
AD 2h : 
LMB 48h [;ssl, 
j, .,. 
LMB 24h : q@j 
Nucleo-cytaplasmic distribution of RRE-containing mRNA in the 
presence of LMB. COS cells cwtransfected with pcREV and pgTAT 
were incubated for 48 h in medium alone (-). in the presence of 
1 p,g ml-’ AD during the last 2 h (AD, Zh), in the presence of 2pM LMB 
for the total incubation time of 48 h (LMB. 48h). or during the last 24 h 
(LMB, 24h). Nuclear (N) and cytoplasmic (Cl RNA were prepared as 
described in the Materials and methods section and equal amounts of 
RNA were probed far RRE-containing RNA and 18s RNA. 
(Fig. 7). In the control cultures and the cells treated with 
AD for 2 h, both nuclear and cytoplasmic RRE-containing 
RNA could be detected (Fig. 6). Using immunofluo- 
rescence, untreated control cultures showed mostly nucle- 
alar and nuclear Rev, but also some cytoplasmic Rev 
(Fig. 7a). While AD induced complete cytoplasmic accu- 
mulation of the Rev protein after Zh (Fig. 7b), it had 
no effect on the localization of RR&containing RNA 
(Fig.6). in the LMB-treated altuxs, however, nuclear 
but nor cytoplasmic RRE could be detected, and the 
amount of 18s RNA was identical to the controls (Fig. 6). 
The immunolocalization of Rev in the LMB-treated czlls 
shows that the protein is sequestered in the nucleus both 
in the absence (Fig. 7~) and in the presence (Fig. 7d) of 
AD duririg rhe last 2 h of the 48 h exposure to the drug. 
The immuaofluorcscencc results obtained after 24h of 
LMB treatment (data nof shown) wcrc identical to those 
shown in Figure 7. These transient transfection results 
indicate that LMB can block not only Kev export to the 
cytoplasm, but also exporr of the RRE-containing RNA 
that depends on Rev for its transport. 
LMB inhibits Rev-dependent, but not Rev-independent 
gene expression 
If RRE-containing RNA is not transported to rhc cytoplasm, 
Kev-dependent gcnc expression should be suppressed, and, 
if this effect is specific for Rev, a Rev- independent plasmid 
should be efticienrly translated in the presence of LMB. 
COS cells were co-transfected with pcREV and pDMt28 
(CAT plasmid, Rev-dependent) and pBClZ/CMV/PGal 
(Rev-independent). After 24h, they were incubated with 
differcnr concentrations of LMB for another 24h, and then 
harvested. CAT and P-galacrosidase levels wc~c determined 
and -divided by the cellular protein content to correct for 
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1 
Effect of LMB on the subcell& localization of 
Rev in transiently transfected COS cells. 
COS ceils co-transfected with pcREV and 
pgTAT were incubated (a) for 48 h in medium 
alone; (b) in the presence af 1 ,~.grnl-l AD 
during the last 2 h; (c)with 2nM LMB for 48h 
and (d) with 2 nM LMB for 48 h and 1 Fg ml-1 
AD during the last 2 h. Cells were then fixed 
and immunostained for Rev a~ described in 
the Materials and methods sectian. Scale bar 
variations in cell number (which after this short-term incu- 
bation did not show any significant growth inhibitory effect 
of the drug). The results shown in Figure 8 are represenra- 
tivc values of three scparatc experiments. While Rev- 
dzpcndcnr CAST expression was maximally suppressed at 
2nM LMB, concenrrations up to 20nM had no effect on 
Rev-independent P-galactosidase expression. Rev-depen- 
dent CAT expression was only suppressed to about 37% of 
untreated controls (27% and 40% in the other two experi- 
mats), because the drug had been added after 24h when 
the cells had already started synthesizing CAT. In a sepa- 
rate set of experiments, where LMB was added 3h after 
transfcction, Rev-dependent CAT expression could be 
reduced to 10% of the control values by 2nM LMB, while 
Rev-independent CA’T expression from a RSV-CAT 
construct was unaffected by 20nM LMB (data not shown). 
LMB inhibits HIV-1 replication in primary human monocytes 
Due fo the cytotoxic effect of LMB after 72h of incubation, 
it was difficult to find a test system in which to assess its 
effect on HIV-l replication.~Most HIV-1 assays arc per- 
formed in actively growing cells and take longer than 72 h. 
However, primary human monocytes, which do not repli- 
cate during several days of incubation, remain metabolically 
active and capable of propagating HIV. ‘The rcsulrs of a 72 h 
incubation of monocytes infected by the BaL strain of HIV- 
1 with LMB are shown in Table 2. Secretion of the 24kDa 
Gag protein (~24) was used as a measure of HIV-l replica- 
tion. LMR at O.6nM significantly inhibited p24 production 
without any appreciable effect on the metabolic raw of the 
cells, as assessed by MTT staining (see the Materials and 
methods sccrion). In another test system, H&a-CD4 cells 
infected with HIV, a similar inhibition of p24 production 
could be observed at 2nM LMB aftcr 24h (data not shown). 
Discussion 
In an attempt to identify a specific inhibitor of the nucleo- 
cycoplasmic translocation of the HIV-l Rev protein, wc iso- 
lated leptomycins A and B and kazusamycins A and B from 
exfracm of a streptwnycetc strain. These drugs had origi- 
nally been characterized as antifungal 130-321 and antirumor 
antibiotics [33-361. They induct: abnormal condensation of 
nuclei [37] and arrest the cell cycle of yeast and mammalian 
cells in both Gl and G2 phases [37,38]. Their mcclranism of 
action is still unknown, however. Investigation of LMB- 
resistant mutants in the fission yeast Sc&~a&~rom~~5 
pum/x led to the idcntificarion of a LMB resistance gene 
that cncodes a protein similar to the mammalian P-glycopro- 
teins that confer multidrug resistance 1391. More spccifi- 
ally, another target gene in S. pombe for LMB is the gene 
that encodes the essential nuclear protein crml, which is 
required for maintaining higher order chromusome stwc- 
rue, correct gem expression and cell growth [40]. Crml is a 
negative regulator of papl, an AP-l-like transcription factor 
in S. pumbc, which is responsible for the expression of a 
2SkDa prorcin (~25). LMB induced the overproducrion of 
~25 in wild-type cells, probably due to activation of pap1 
through repression of crml. The molecular mechanism for 
crml action is still unknown, howevcr [4O]. 
Our results on the inhibition of HIV-I Rev nuclear export 
raises the intriguing possibility that this target gene of LMB 
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Effect of LMS on gene expressibn. COS cells were co-transfected 
with pcRE”, pDMl28 and pBC1 Z/CMV/@Gal. After 24h. graded 
cmxentrations of LMS were added for another 24 h. Cells were then 
harvested. and CAT (0) and p galactosidase (0) activities, as well as 
cellular protein content per well, were determined as described in the 
Materials and methods section. 
or another, as yet unidentified, target gene, is involved 
in nucleo-cyroplasmic transport processes. Recently, it was 
shown that Rev exploits the rransport pathway that is 
normally used for SS rRNA and CJl snRNA [21j, whereas 
mRNA , tRNA and ribosomal export are directed via a 
different mutt. The activation domain of Rev was charac- 
terized as the nuclear export signal by transport studies 
using dominant-negative mutants [18-201 and by linking 
the domain to a reporter protein [21,22]. Similar export 
signals were identified in the human T-cell leukemia virus 
type 1 (HTLV-1) regulatory protein Rex [41], mitogen-acti- 
vated protein kinase kinase 1421, protein kinase inhibitor a 
(PKIrr) [Z’Z], the I& protein [43], and in the amphibian 
protein TFIIIA, which binds to SS rRNA transcripts and 
has been proposed to be involved in the efficient nuclear 
export of 5s [RNA in amphibian oocytes [441. LMB could 
conceivably be a specific blocking agent for this nuclear 
cxport pathway. Our results indicate that Rev-dependent 
gene expression was blocked, while Rev-independent gene 
Table 2 
IWed of LMB on ~24 production in HIV-infected primary 
human monocytes. 
LMB (nM) 1124 bgml-‘) MTT (00) 
233+75 251*123 
0.2 2723~98 253+27 
0.6 m.3+23.5 233+107 
2 54*9x 299?192 
6 x3*,3 214+135 
Primary human manocytes were infected with HIV.1 BaL for 48 h. LMB 
was then added for 72 h. Levels of ~24 were determined in the 
supernatant, and cellular e~terase activity was measured by the Mm 
method, as described in the Materials and methods section. Results 
are means f SD. of triplicate experiments. Values of p24 in untreated 
contr& at the beginning of the 72 h incubation period were 
42 pg ml-‘. Values of ~24 for 0.6 nM. 2 nM and 6 nM LMB were 
significantly different from the untreated controls. as evaluated by a 
two-tailed t-test (p values <0.05. -CO.02 and <0.02. respectively). 
There was no significant difference among the MTT values. 
expression, which should occur via the mRNA cxport 
pathway(s), was unaffected over a period of 24h. A block of 
the SS rKNA and Ul snRNA transport systems would also 
explain the long-term toxicity of leptomycin B in tissue 
culture. Therefore, even though LMB blocks Rev export 
and function, and can inhibit HIV, replication in primary 
human monocyres, LMB cannot be used therapeutically. It 
should, however, provide a valuable tool for dissecting 
nuclear transport pathways. The effects of LMB on the 
export of SS rRNA, Ul snRNA and several nuclear proteins 
are currently under investigation. 
Significance 
The export of the Rev protein of HIV-1 from the 
nucleus to the cytoplasm of infected cells has been 
shown to depend on n specific nuclear export signal in 
the sequence of Rev [21,221 and homologous sequences 
have been ‘found in several other proteins [22,41-441. 
This suggests that these proteins may al1 be exported 
from the nucleus to the cytoplasm by a common 
pathway. In addition this pathway appears to be used by 
some RNA species (unspliced and singly spliced HIV-1 
mRNA, SS rRNA and Ul snRNA) [4,5,211. but not by 
the bulk of mRNA. We show here that leptomycin B 
(LMB) and three other structurally related antibiotics 
from Str@tonzyces can completely block export of Rev 
from the nucleus. These are the first low molecuInr 
weight compounds known to have this inhibitory func- 
tion. LMB appears to be a specific probe for this 
pathway because it affects Rev-associated export, but 
not Rev-independent export processes. Furthermore, we 
show that LMB is a probe for nuclear export only, 
because the nuclear import of Rev and other nuclear 
proteins is unaffected by the drug. LMB should be a 
valuable tool with which to dissect nuclear export path- 
waysof different protein and RNA species. 
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Materials and methods 
Isolation and purification of leptomycin and kazusamycin 
antibiotics 
Leptomycins A and 8 and kazusamycins A and B were isolated from 
the Streptomyces sp. strain A87-18203, which was deposited with 
the Deutsche Sammlung van Mikroorganismen und Zellkulturen. 
Mascherod& Weg 1 b, D.3300 Sraunschweig. Germany (reference 
number DSM 7517). Ethyl acetate extracts of Streptomyces A87. 
18203 were fractionated by gel filtration an Sephadex LH-20 (Pharma- 
cia). Four compounds were isolated by preparative HPLC as will be 
described elsewhere (Y. Wang et al., unpublished observations). The 
structures and the stereochemistry were established by spectroscopic 
and chemical methods. 
Rev nucleo-cytoplasmic translocatkx assay 
HeLa-Rev cells are HeLa cells stably transfected with an expression 
plasmid far HIV-I Rev [291 and selected by co-transfection with the 
gene for dihydrololate reductase. The original cells were a generous 
gift from B.R. Cullen and were grown in Iscove’s modified Dulbecca’s 
medium (IMDM) supplemented with 10% heat-inactivated fetal calf 
serum and 1 OOnM amethapterin. These cells were subcloned to 
achieve a high level of Rev expression in all cells. and clone 403E3 
was used for all localization experiments. 
Cells were seeded into W-well plates (Nunc) and synchronized by 
serum starvation lor 48 h. Rev synthesis was induced by the addition of 
serum. At this time, test compounds or streptomycete broth extracts 
were added in complete medium lacking amethopterin and incubated 
with the cells for a total of 7 h. During the last 2 h. actinomycin D (AD; 
Sigma) was added at 1 pgmi-’ in order to induce complete cytoplae 
mic localization of Rev in the medium controls [I 81. The cells were then 
fixed and immunastained for Rev protein using a mouse monoclonal 
antibody against Rev and a dichlorotriarinyl amino fluorescein (DTAF)- 
lab&d goat-anti-mouse antibody as described elsewhere I1 81. 
Inhibitors of Rev translocation into the cytoplasm were identified by 
microscopic examination of individual wells using a 32x objective an a 
Zeiss IM IO inverted microscope equipped with epifluorescence 
optics. For the images shown in Figures 2 and 3, cells were grown on 
8-well Lab-Tek chamber slides (Nunc). immunostained for Rev and 
examined in a BioRad MRC 600 confocal laser scanning microscope 
as described [I 81. Results in Figures ?a, 2b and 3 are represented as 
0.7 &rn thick optical sections, while Figure 2c and 2d show optical sec- 
tions of 1.8 vrn thickness. 
In order to assess the influence of LMB on Rev translocation from the 
cytoplasm into the nucleus. HeLa-Rev cells were serum-starved for 
48 h. and the drug was added 1 h before the re-addition of serum. 
COS cells in 6-well plates (Nunc) were transfected and treated with 
AD and LMB as described below (RNA transport assay) and immunos- 
tained for Rev. They were examined in an Olympus IX-70 inverted 
microscope equipped with a 100 x (1.35 N.A.) objective and epifluarew 
cence optics and photographed with a PM-30 camera (Olympus) using 
TMav 400 film (Eastman Kodak). 
NFKB p6.5 nuclear import assay 
HeLa cells (ATCC, Rackville. MD, USA) were grown in IMDM supple- 
mented with 10% heat%activated fetal calf serum. They were 
seeded into B-well LabTek chamber slides and allowed lo adhere 
overnight. They were then stimulated by the addition of 200 U ml-’ 
TN& (Boehringer Mannheim. Germany) for 30 min. LMB (1 +M) was 
added for SO min before and during the stimulation. The cells were 
fixed and permeabilized with 4% paraformaldehyde and 0.5% Triton- 
X1 00, respectively. The cells were immunostained using a polyclonal 
rabbit antibody directed against NFKB ~65 (Santa Cruz Biatechnol- 
ogy) and a tetramethylrhodamine-labelled goat-anti-rabbit antibody 
(Accurate Scientific) and examined by confocal laser scanning 
microscopy as described [I 81. 
The in vftra nuclear impoit assay was conducted as described far FAGS 
analvsis L271. The suswnsion of nuclei was transierred to a alass slide 
and examined in the Olympus microscope as described above. 
RNA transport assay 
COS cells were seeded into T150 flasks (Nunc) and transfected with 
expression plasmids pcREV [291 and pgTAT [291 at 1 sgml-’ and 
1.5 +gml-‘, respectively, using DEAE-dextran and chloraquine [45]. 
LMS was added at 2 nM for 24 h or 48 h; in one sample, AD was 
added 2 h prior to the end of the experiment. Total incubation time after 
transfection was 48 h. Nuclear and cytoplasmic RNAs were prepared 
according to 1461. and slot blot analysis was performed using probes 
specific for RRE WCCT GTA CCG TCA GCG TCA XG ACG CTG 
CGC-3’) and 185 RNA WGCA CCA GAC TTG CCC TCC AAT 
GGA TCC TCG-3’). 
Reporter gene assays 
CCS cells were co-transfected with pcREV (1 kgml-I), a R&depen- 
dent chloramphenical acetyl transferase (CAT) indicator gene 
(pDM128; 1.5 pgml-‘) [471 and a Rev-independent gene for the 
expression of p-galactosidase (pBC12ICMVIPGal; 1 pg ml-‘) [481 in 
6-well plates (Costar). 24 h after transfection, different concentrations 
of LMB were added to the ceils, and incubation was continued for 
another 24 h. The cells were prepared for the simultaneous determina- 
tion of CAT and P-galactasidase activities as described [491. Cellular 
protein was determined from an aliquot of the suspended cells, 
digested in 0.5 M N&H. using the BioRad protein assay. 
HIV-1 ~2’4 Gag protein production in primary human 
monocytes 
Five-day adherent monocyte cultures were prepared from the blood oi 
healthy, HIV-negative donors [501. The cells were maintained in 48.well 
plates (Costar). They were infected with HIV-I BaL strain for 48 h, and 
LME was then added at different concentrations. Three days after sub- 
stance addition. p24 Gag protein was measured in the supernatant 
using a commercially available ELISA kit (Coulter). The cell number per 
well was determined using the MTT method [51]. 
Sulforhodamine B assay 
In order to determine the effect of the drugs on cell growth, HeLa-Rev 
cells were seeded into g&well plates at 5000 cells per well and allowed 
to adhere overnight. They were then incubated with test compounds for 
7 h, 24 h, 48 h or 72 h. fixed with 3.7% formaldehydeW/o sucrose in 
PBS and stained with sulforhodamine B (Sigma) as described WI. 
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